Literature DB >> 25386224

Patients' Perspectives on Integrating Acupuncture into the Radiation Oncology Setting.

Eitan Frankel1, Sheila Garland2, Salimah H Meghani3, Neha Vapiwala4, Jun J Mao5.   

Abstract

INTRODUCTION: Acupuncture has potential as a supportive care service for cancer symptom management. However, little is known about patients' willingness to use acupuncture in the context of conventional cancer care.
METHODOLOGY: We conducted a cross-sectional survey study among patients with cancer during their last week of fractionated/external beam radiotherapy (RT). The main outcome variable was self-reported likelihood of using acupuncture during RT. Knowledge about acupuncture and pain severity was measured along with socio-demographic and clinical variables. Multivariate logistic regression was performed to identify factors associated with willingness to use acupuncture.
RESULTS: Among the 305 participants, 79 (26.4%) were likely to use acupuncture during RT if such services were offered at a reasonable price, 143 (46.9%) had no knowledge of acupuncture, and 206 (67.6%) reported having pain. In multivariate analyses, non-Whites (adjusted odds ratio [AOR] 1.94, 95% Confidence Interval [CI] 1.06-3.56), and those with pain (AOR 2.52, CI 1.25-5.10) were more interested in using acupuncture. In addition, patients with preexisting knowledge about acupuncture were also more likely to use acupuncture than those without this knowledge (AOR 2.23, CI 1.28-3.88).
CONCLUSIONS: Patients of non-White race, those with pain or those with prior knowledge about acupuncture were more willing to utilize acupuncture during RT. Since half of the patients had no knowledge about acupuncture, interventions to improve patients' knowledge are needed to facilitate the successful integration of acupuncture into cancer care.

Entities:  

Keywords:  Acupuncture; CAM; health disparity; knowledge; pain; radiotherapy

Year:  2014        PMID: 25386224      PMCID: PMC4224313          DOI: 10.1016/j.eujim.2014.06.007

Source DB:  PubMed          Journal:  Eur J Integr Med        ISSN: 1876-3820            Impact factor:   1.314


  28 in total

1.  Complementary and alternative medicine use among cancer survivors: a population-based study.

Authors:  Jun James Mao; Christina Shearer Palmer; Kaitlin Elizabeth Healy; Krupali Desai; Jay Amsterdam
Journal:  J Cancer Surviv       Date:  2010-10-06       Impact factor: 4.442

2.  Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer.

Authors:  Jane T Hickok; Joseph A Roscoe; Gary R Morrow; Karen Mustian; Paul Okunieff; Christopher W Bole
Journal:  Cancer       Date:  2005-10-15       Impact factor: 6.860

3.  The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines.

Authors:  Geoff Delaney; Susannah Jacob; Carolyn Featherstone; Michael Barton
Journal:  Cancer       Date:  2005-09-15       Impact factor: 6.860

Review 4.  Oral complications of radiotherapy.

Authors:  James J Sciubba; David Goldenberg
Journal:  Lancet Oncol       Date:  2006-02       Impact factor: 41.316

5.  Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.

Authors:  Philippe L Bedard; Monika K Krzyzanowska; Melania Pintilie; Ian F Tannock
Journal:  J Clin Oncol       Date:  2007-08-10       Impact factor: 44.544

6.  Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial.

Authors:  David G Pfister; Barrie R Cassileth; Gary E Deng; K Simon Yeung; Jennifer S Lee; Donald Garrity; Angel Cronin; Nancy Lee; Dennis Kraus; Ashok R Shaha; Jatin Shah; Andrew J Vickers
Journal:  J Clin Oncol       Date:  2010-04-20       Impact factor: 44.544

7.  A prospective observational trial on emesis in radiotherapy: analysis of 1020 patients recruited in 45 Italian radiation oncology centres.

Authors:  Ernesto Maranzano; Verena De Angelis; Stefano Pergolizzi; Marco Lupattelli; Paolo Frata; Stefano Spagnesi; Maria Luisa Frisio; Giovanni Mandoliti; Giuseppe Malinverni; Fabio Trippa; Letizia Fabbietti; Salvatore Parisi; Annamaria Di Palma; Pietro De Vecchi; Costantino De Renzis; Celestino Giorgetti; Tiziano Bergami; Roberto Orecchia; Maurizio Portaluri; Marco Signor; Davide Di Gennaro
Journal:  Radiother Oncol       Date:  2009-12-04       Impact factor: 6.280

8.  Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases.

Authors:  R L Daut; C S Cleeland; R C Flanery
Journal:  Pain       Date:  1983-10       Impact factor: 6.961

9.  One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient.

Authors:  Anna Enblom; Beata Bergius Axelsson; Gunnar Steineck; Mats Hammar; Sussanne Börjeson
Journal:  Support Care Cancer       Date:  2008-06-05       Impact factor: 3.603

10.  Cancer survivors with unmet needs were more likely to use complementary and alternative medicine.

Authors:  Jun J Mao; Steve C Palmer; Joseph B Straton; Peter F Cronholm; Shimrit Keddem; Kathryn Knott; Marjorie A Bowman; Frances K Barg
Journal:  J Cancer Surviv       Date:  2008-04-15       Impact factor: 4.442

View more
  2 in total

1.  What if Acupuncture Were Covered by Insurance for Pain Management? A Cross-Sectional Study of Cancer Patients at One Academic Center and 11 Community Hospitals.

Authors:  Kevin T Liou; Tony K W Hung; Salimah H Meghani; Andrew S Epstein; Q Susan Li; Sally A D Romero; Roger B Cohen; Jun J Mao
Journal:  Pain Med       Date:  2019-10-01       Impact factor: 3.750

Review 2.  Acupuncture for cancer pain: an evidence-based clinical practice guideline.

Authors:  Long Ge; Qi Wang; Yihan He; Darong Wu; Qi Zhou; Nenggui Xu; Kehu Yang; Yaolong Chen; Anthony Lin Zhang; Haiqing Hua; Jinchang Huang; Ka-Kit Hui; Fanrong Liang; Linpeng Wang; Bin Xu; Yufei Yang; Weimin Zhang; Baixiao Zhao; Bing Zhu; Xinfeng Guo; Charlie Changli Xue; Haibo Zhang
Journal:  Chin Med       Date:  2022-01-05       Impact factor: 5.455

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.